Mining the Synergistic Core Allosteric Modules Variation and Sequencing Pharmacological Module Drivers in a Preclinical Model of Ischemia

Identifying the variation of core modules and hubs seems to be critical for characterizing variable pharmacological mechanisms based on topological alteration of disease networks. We first identified a total of eight core modules by using an approach of multiple modular characteristic fusing (MMCF) from different targeted networks in ischemic mice. Interestingly, the value of module disturbance intensity (MDI) increased in drug combination group. Second, we redefined a weak allosteric module and a strong allosteric module. Then, we identified 15 pharmacological module drivers (PMDs) by leave‐one‐out screening with a cutoff of two folds, which were at least, in part, validated by expression and variation of topological contribution. Finally, we revealed the fusional and emergent variation of PMD in core modules contributing to multidimensional synergistic mechanism in ischemic mice and rats. Our findings provide a new set of drivers that might promote the pharmacological modular flexibility and offer a potential avenue for disease treatment.

[1]  Tang,et al.  Self-Organized Criticality: An Explanation of 1/f Noise , 2011 .

[2]  Yanan Yu,et al.  Decoding the Polyphyletic Flexibility of Allosteric Modular Networks: Progress and Perspectives. , 2016, Critical reviews in eukaryotic gene expression.

[3]  Rajeev Motwani,et al.  The PageRank Citation Ranking : Bringing Order to the Web , 1999, WWW 1999.

[4]  Hiroaki Kitano,et al.  Biological robustness , 2008, Nature Reviews Genetics.

[5]  Albert-László Barabási,et al.  Scale-Free Networks: A Decade and Beyond , 2009, Science.

[6]  F. P. Roth,et al.  Discovering the Targets of Drugs Via Computational Systems Biology , 2011, The Journal of Biological Chemistry.

[7]  Zhong Wang,et al.  Modular pharmacology: the next paradigm in drug discovery , 2012, Expert opinion on drug discovery.

[8]  Duncan J. Watts,et al.  Collective dynamics of ‘small-world’ networks , 1998, Nature.

[9]  Marián Boguñá,et al.  Extracting the multiscale backbone of complex weighted networks , 2009, Proceedings of the National Academy of Sciences.

[10]  Jun Liu,et al.  Convergent and Divergent Pathways Decoding Hierarchical Additive Mechanisms in Treating Cerebral Ischemia–Reperfusion Injury , 2014, CNS neuroscience & therapeutics.

[11]  U Dirnagl,et al.  Mild Cerebral Ischemia Induces Loss of Cyclin-Dependent Kinase Inhibitors and Activation of Cell Cycle Machinery before Delayed Neuronal Cell Death , 2001, The Journal of Neuroscience.

[12]  Khan M. Iftekharuddin,et al.  Learning topological image transforms using cellular simultaneous recurrent networks , 2013, The 2013 International Joint Conference on Neural Networks (IJCNN).

[13]  Kwang-Hyun Cho,et al.  The core regulation module of stress-responsive regulatory networks in yeast , 2012, Nucleic acids research.

[14]  Raphael Lamed,et al.  Revisiting the NMR solution structure of the Cel48S type-I dockerin module from Clostridium thermocellum reveals a cohesin-primed conformation. , 2014, Journal of structural biology.

[15]  J. Bos,et al.  DEP domains: structurally similar but functionally different , 2014, Nature Reviews Molecular Cell Biology.

[16]  Zhan-Jun Zhang,et al.  Synergistic Mechanism of Gene Expression and Pathways between Jasminoidin and Ursodeoxycholic Acid in Treating Focal Cerebral Ischemia–Reperfusion Injury , 2012, CNS neuroscience & therapeutics.

[17]  Ying Fan,et al.  Identifying and Characterizing Nodes Important to Community Structure Using the Spectrum of the Graph , 2011, PloS one.

[18]  S. Thiagalingam,et al.  A cascade of modules of a network defines cancer progression. , 2006, Cancer research.

[19]  Delbert Dueck,et al.  Clustering by Passing Messages Between Data Points , 2007, Science.

[20]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[21]  J. Blenis,et al.  The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. , 2011, Trends in biochemical sciences.

[22]  Sten Ohlson,et al.  Designing transient binding drugs: a new concept for drug discovery. , 2008, Drug discovery today.

[23]  Rong Jin,et al.  Reconstruct modular phenotype-specific gene networks by knowledge-driven matrix factorization , 2009, Bioinform..

[24]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[25]  R. P. Stroemer,et al.  Cortical Protection by Localized Striatal Injection of IL-1ra Following Cerebral Ischemia in the Rat , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  Gary D. Bader,et al.  An automated method for finding molecular complexes in large protein interaction networks , 2003, BMC Bioinformatics.

[27]  Shilpa Chakravartula,et al.  Complex Networks: Structure and Dynamics , 2014 .

[28]  H. Stanley,et al.  Introduction to Phase Transitions and Critical Phenomena , 1972 .

[29]  Herwig Unger,et al.  Node Behaviour Driven Network Topology Adaption , 2012, Autonomous Systems: Developments and Trends.

[30]  Francis J. Doyle,et al.  Core module biomarker identification with network exploration for breast cancer metastasis , 2012, BMC Bioinformatics.

[31]  D. Galas,et al.  Diseases as network perturbations. , 2010, Current opinion in biotechnology.

[32]  Ruth Nussinov,et al.  Attractor Structures of Signaling Networks: Consequences of Different Conformational Barcode Dynamics and Their Relations to Network‐Based Drug Design , 2014, Molecular informatics.

[33]  Albert-László Barabási,et al.  Control Centrality and Hierarchical Structure in Complex Networks , 2012, PloS one.

[34]  S. Havlin,et al.  Self-similarity of complex networks , 2005, Nature.

[35]  Ruth Nussinov,et al.  Structure and dynamics of molecular networks: A novel paradigm of drug discovery. A comprehensive review , 2012, Pharmacology & therapeutics.

[36]  Bing Li,et al.  Quantitative Determination of Flexible Pharmacological Mechanisms Based On Topological Variation in Mice Anti-Ischemic Modular Networks , 2016, PloS one.

[37]  Jun Liu,et al.  Fusion of core pathways reveals a horizontal synergistic mechanism underlying combination therapy. , 2011, European journal of pharmacology.

[38]  Anton J. Enright,et al.  An efficient algorithm for large-scale detection of protein families. , 2002, Nucleic acids research.

[39]  Ching-tai Lin.  Structural controllability , 1974 .

[40]  Csaba Böde,et al.  Perturbation waves in proteins and protein networks: applications of percolation and game theories in signaling and drug design. , 2008, Current protein & peptide science.

[41]  M. L. Martins,et al.  Boolean Network Model for Cancer Pathways: Predicting Carcinogenesis and Targeted Therapy Outcomes , 2013, PloS one.

[42]  William H. Frey,et al.  Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion , 2001, Neuroscience Letters.

[43]  Leonard M. Freeman,et al.  A set of measures of centrality based upon betweenness , 1977 .

[44]  Albert-László Barabási,et al.  Observability of complex systems , 2013, Proceedings of the National Academy of Sciences.

[45]  A. Vespignani,et al.  The architecture of complex weighted networks. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[46]  P. Sorger,et al.  Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks , 2012, Cell.

[47]  Yinying Chen,et al.  Spatiotemporal positioning of multipotent modules in diverse biological networks , 2014, Cellular and Molecular Life Sciences.

[48]  Wu Jun.  Network Structure Entropy and Its Application to Scale-free Networks , 2004 .

[49]  A Díaz-Guilera,et al.  Self-similar community structure in a network of human interactions. , 2003, Physical review. E, Statistical, nonlinear, and soft matter physics.